| Kate Pitz, MD | |
|
1 Hospital Dr # Mc404, Columbia, MO 65212-1000 | |
| (573) 884-2000 | |
| (573) 884-4611 |
| Full Name | Kate Pitz |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 1 Hospital Dr # Mc404, Columbia, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437644705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2018022816 (Missouri) | Primary |
| Entity Name | University Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669456257 PECOS PAC ID: 1153235825 Enrollment ID: O20031117000701 |
News Archive
Resveratrol, a chemical found in red grapes, is more effective in smaller doses at preventing bowel cancer in mice than high doses, according to new research published today (Wednesday) in the journal Science Translational Medicine.
Today, the New York Stem Cell Foundation Research Institute and PersonalGenomes.org announced a partnership to identify genetic and environmental contributions to trait and disease development. Cell lines generated by NYSCF will complement genomic data and medical histories contributed by participants in the Harvard Personal Genome Project, creating a unique and powerful resource to help researchers identify causes of disease.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kate Pitz, MD 1 Hospital Dr # Mc404, Columbia, MO 65212-1000 Ph: (573) 884-2000 | Kate Pitz, MD 1 Hospital Dr # Mc404, Columbia, MO 65212-1000 Ph: (573) 884-2000 |
News Archive
Resveratrol, a chemical found in red grapes, is more effective in smaller doses at preventing bowel cancer in mice than high doses, according to new research published today (Wednesday) in the journal Science Translational Medicine.
Today, the New York Stem Cell Foundation Research Institute and PersonalGenomes.org announced a partnership to identify genetic and environmental contributions to trait and disease development. Cell lines generated by NYSCF will complement genomic data and medical histories contributed by participants in the Harvard Personal Genome Project, creating a unique and powerful resource to help researchers identify causes of disease.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 4 days ago
Olivia Louise Bolles, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-4141 | |
Alice Lee, Surgery Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-5609 Fax: 573-884-6054 | |
Ioan-andrei Scumpu, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Mchaney Hall 404, Dco75.00, Columbia, MO 65212 Phone: 573-884-2000 | |
Marc L Miller, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 115 Business Loop 70 W, Columbia, MO 65203 Phone: 573-882-8454 Fax: 573-884-6054 | |
Dr. Mary Carr, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Brent W Miedema, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr # 617, Columbia, MO 65201 Phone: 573-814-6346 | |
Richard Smith, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Drive, Columbia, MO 65201 Phone: 573-884-4854 Fax: 573-884-6054 |